G. St-Germain (1988)
Etude de 100 souches de levures isolées de spécimens cliniques normalement stériles, 17
F. Lunel, J. Meis, A. Voss (1999)
Nosocomial fungal infections: candidemia.Diagnostic microbiology and infectious disease, 34 3
P. Fidel, J. Vázquez, J. Sobel (1999)
Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison toC. albicansClinical Microbiology Reviews, 12
A. Colombo, M. Nucci, R. Salomão, M. Branchini, R. Richtmann, Andrea Derossi, S. Wey (1999)
High rate of non-albicans candidemia in Brazilian tertiary care hospitals.Diagnostic microbiology and infectious disease, 34 4
T. Hadfield, Michael Smith, R. Winn, M. Rinaldi, Cleste Guerra (1987)
Mycoses caused by Candida lusitaniae.Reviews of infectious diseases, 9 5
M. Nguyen, C. Clancy, Victor Yu, Yue Yu, A. Morris, D. Snydman, D. Sutton, Michael Rinaldi, M Nguyen, N. Zealand. (1998)
Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.The Journal of infectious diseases, 177 2
M. Pfaller, Ronald Jones, G. Doern, H. Sader, S. Messer, A. Houston, S. Coffman, R. Hollis (2000)
Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998Antimicrobial Agents and Chemotherapy, 44
J. Edwards, G. Bodey, R. Bowden, Thomas Bü, B. Pauw, S. Filler, M. Ghannoum, M. Glauser, R. Herbrecht, C. Kauffman, Shigeru Kohno, Pietro Martino, F. Meunier, Takeshi Mori, M. Pfaller, J. Rex, Thomas Rogers, R. Rubin, J. Solomkin, C. Viscoli, T. Walsh, M. White, Medi (1997)
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 25 1
M. Pfaller, S. Messer, S. Coffmann (1995)
Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870Journal of Clinical Microbiology, 33
W. Jarvis (1995)
Epidemiology of nosocomial fungal infections, with emphasis on Candida species.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 20 6
D. Yamamura, C. Rotstein, L. Nicolle, Stratis Ioannou (1999)
Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 160 4
J. Rex, M. Rinaldi, M. Pfaller (1995)
Resistance of Candida species to fluconazoleAntimicrobial Agents and Chemotherapy, 39
S. Revankar, W. Kirkpatrick, R. Mcatee, A. Fothergill, S. Redding, M. Rinaldi, T. Patterson (1998)
Interpretation of Trailing Endpoints in Antifungal Susceptibility Testing by the National Committee for Clinical Laboratory Standards MethodJournal of Clinical Microbiology, 36
(1998)
Steinbakk, and the Norwegian Yeast Study Group
M. Nguyen, J. Peacock, A. Morris, D. Tanner, Minh-Ly Nguyen, D. Snydman, M. Wagener, M. Rinaldi, V. Yu (1996)
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.The American journal of medicine, 100 6
A. Kao, M. Brandt, W. Pruitt, L. Conn, B. Perkins, D. Stephens, W. Baughman, A. Reingold, G. Rothrock, M. Pfaller, R. Pinner, R. Hajjeh (1999)
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 29 5
M. Pfaller, S. Messer, R. Hollis, R.N Jones, G. Doern, M.E Brandt, R.A Hajjeh (1999)
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.Diagnostic microbiology and infectious disease, 33 4
M. Nguyen, J. Peacock, D. Tanner, A. Morris, Minh-Ly Nguyen, D. Snydman, M. Wagener, V. Yu (1995)
Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.Archives of internal medicine, 155 22
J. Rex, P. Nelson, V. Paetznick, M. Lozano-Chiu, A. Espinel-Ingroff, E. Anaissie (1998)
Optimizing the Correlation between Results of Testing In Vitro and Therapeutic Outcome In Vivo for Fluconazole by Testing Critical Isolates in a Murine Model of Invasive CandidiasisAntimicrobial Agents and Chemotherapy, 42
M. Tornatore, G. Noskin, D. Hacek, A. Obias, L. Peterson (1997)
Effects of incubation time and buffer concentration on in vitro activities of antifungal agents against Candida albicansJournal of Clinical Microbiology, 35
P. Wayne (2002)
Reference method for broth dilution antifungal susceptibility testing of yeasts, Approved standard-second edition
E. Bruck (1980)
National Committee for Clinical Laboratory Standards.Pediatrics, 65 1
G. St-Germain (2001)
Impact of endpoint definition on the outcome of antifungal susceptibility tests with Candida species: 24‐ versus 48‐h incubation and 50 versus 80% reduction in growthMycoses, 44
P. Sandven, L. Bevanger, A. Digranes, P. Gaustad, H. Haukland, M. Steinbakk (1998)
Constant Low Rate of Fungemia in Norway, 1991 to 1996Journal of Clinical Microbiology, 36
D. Abi‐Said, E. Anaissie, O. Uzun, I. Raad, Helio Pinzcowski, S. Vartivarian (1997)
The epidemiology of hematogenous candidiasis caused by different Candida species.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 24 6
M. Pfaller, S. Messer, A. Houston, M. Rangel-Frausto, T. Wiblin, H. Blumberg, J. Edwards, W. Jarvis, W. Jarvis, M. Martin, H. Neu, L. Saiman, J. Patterson, J. Dibb, C. Roldán, M. Rinaldi, R. Wenzel (1998)
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.Diagnostic microbiology and infectious disease, 31 1
Mitchell Goldman, John Pottage, Denise Weaver (1993)
Candida krusei fungemia. Report of 4 cases and review of the literature.Medicine, 72 3
M. Nguyen, Christine Yu (1999)
Influence of Incubation Time, Inoculum Size, and Glucose Concentrations on Spectrophotometric Endpoint Determinations for Amphotericin B, Fluconazole, and ItraconazoleJournal of Clinical Microbiology, 37
T. Sterling, W. Merz (1998)
Resistance to amphotericin B: emerging clinical and microbiological patterns.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 1 3
J. Rex, J. Bennett, A. Sugar, P. Pappas, J. Serody, J. Edwards, R. Washburn (1995)
Intravascular Catheter Exchange and Duration of CandidemiaClinical Infectious Diseases, 21
J. Rex, C. Cooper, W. Merz, J. Galgiani, E. Anaissie (1995)
Detection of amphotericin B-resistant Candida isolates in a broth-based systemAntimicrobial Agents and Chemotherapy, 39
Journal of Clinical Microbiology – Unpaywall
Published: Mar 1, 2001
Access the full text.
Sign up today, get DeepDyve free for 14 days.